Loading…
20/20 Biolabs, Inc. is projected to decline to $0.387 by 2027, a -9% move from its current price of $0.4258. AIDX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.4026 | $0.4258 | $0.4503 | 0.00% |
| Aug 6 | $0.3934 | $0.4258 | $0.4609 | 0.00% |
| Aug 7 | $0.3864 | $0.4258 | $0.4691 | -0.01% |
| Aug 8 | $0.3807 | $0.4258 | $0.4762 | -0.01% |
| Aug 9 | $0.3756 | $0.4258 | $0.4826 | -0.01% |
| Aug 10 | $0.3712 | $0.4257 | $0.4883 | -0.01% |
| Aug 11 | $0.3671 | $0.4257 | $0.4937 | -0.01% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.3671 | $0.4257 | $0.4937 | -0.01% |
| Week 2 | $0.3452 | $0.4257 | $0.5249 | -0.03% |
| Week 3 | $0.3293 | $0.4256 | $0.5501 | -0.04% |
| Week 4 | $0.3164 | $0.4256 | $0.5723 | -0.06% |
| Week 5 | $0.3055 | $0.4255 | $0.5926 | -0.07% |
| Week 6 | $0.296 | $0.4254 | $0.6116 | -0.08% |
| Week 7 | $0.2874 | $0.4254 | $0.6295 | -0.10% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
20/20 Biolabs, Inc. (AIDX) is a Healthcare company that develops and commercializes AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. It offers OneTest for Cancer, a multi-cancer early detection (MCED), and OneTest for Longevity, which measures inflammatory biomarkers.
It also operates the Clinical Lab Innovation Axcelerator (CLIAx), a CLIA laboratory for overseas diagnostics start-ups.
The company was formerly known as 20/20 GeneSystems, Inc. and changed its name to 20/20 Biolabs, Inc. in March 2025. It was incorporated in 2000 and is based in Gaithersburg, Maryland.
AIDX is trading at $0.4011 with a market cap of $4.91M and a market rank of 5006. The current price sits near a defined support level of $0.40 and below a resistance level of $0.66, with the 30-day range spanning $0.2819 to $0.5707. The near-term outlook is neutral as of the latest technical snapshot.
A major floor 44.4% below — a decisive break under it would weaken the trend.
The nearest floor, 6.1% below — buyers have tended to step in here.
The nearest ceiling, 55.0% above — a clean break opens room to run.
A major ceiling 374.4% above — clearing it would confirm fresh momentum.
Key AIDX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AIDX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.436 | Sell | $0.4406 | Sell |
| MA 10 | $0.479 | Sell | $0.4696 | Sell |
| MA 20 | $0.5235 | Sell | $0.5221 | Sell |
| MA 50 | $0.6884 | Sell | $1.01 | Sell |
| MA 100 | $1.23 | Sell | $3.48 | Sell |
| MA 200 | — | Neutral | — | Neutral |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 30.72 | Neutral |
| Stoch RSI (14) | 54.13 | Neutral |
| CCI (20) | -124.29 | Sell |
| Williams %R (14) | -80.00 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | -21.82 | Sell |
| Bollinger %B (20,2) | 0.11 | Neutral |
| Stochastic %K (14) | 20.00 | Neutral |
| TRIX (15) | -1.72 | Sell |
| Awesome (5,34) | -0.13 | Sell |
| Ultimate (7,14,28) | 24.05 | Buy |
| Momentum (10) | -0.09 | Sell |
| Aroon Osc (25) | -72.00 | Sell |
| Hull MA (9) | 0.40 | Buy |
| ADX (14) | 40.54 | Sell |
| ATR (14) | 0.03 | Info |
The technical picture shows a neutral sentiment, with RSI14 at 30. The price is currently below the 50-day simple moving average of $0.7066, suggesting limited near-term upside relative to that benchmark.
In the last 30 days, the price traded between $0.2819 and $0.5707, with strong near-term support at $0.40 and immediate resistance at $0.66. This context helps frame potential move directions, though the near-term view remains balanced and uncertain given the current indicators.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.40 | $0.4258 | $0.6341 | 0% | Neutral | |
| $0.2546 | $0.387 | $0.6364 | -9% | Neutral | |
| $0.2381 | $0.4017 | $0.7205 | -6% | Neutral | |
| $0.1936 | $0.3584 | $0.6859 | -16% | Bearish | |
| $0.168 | $0.3393 | $0.6845 | -20% | Bearish | |
| $0.187 | $0.4112 | $0.8673 | -3% | Neutral | |
| $0.2365 | $0.5255 | $1.15 | +23% | Bullish | |
| $0.2569 | $0.5709 | $1.30 | +34% | Bullish | |
| $0.224 | $0.4978 | $1.15 | +17% | Neutral | |
| $0.215 | $0.4777 | $1.10 | +12% | Neutral | |
| $0.3231 | $0.7181 | $1.65 | +69% | Bullish | |
| $0.4119 | $0.9153 | $2.11 | +115% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.40 | $0.4258 | $0.5747 | +0.00% |
| September 2026 | $0.3571 | $0.447 | $0.591 | +4.97% |
| October 2026 | $0.3324 | $0.425 | $0.5785 | -4.91% |
| November 2026 | $0.3346 | $0.4356 | $0.6066 | +2.48% |
| December 2026 | $0.3372 | $0.4462 | $0.6341 | +2.43% |
Click any year to see its month-by-month AIDX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect AIDX to range from $0.40 to $0.6341 through 2026. The $0.4258 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The AIDX price prediction for 2027 points to an average of $0.387 (low $0.2546, high $0.6364) — a potential decline of -9% on today's $0.4258. Price action looks broadly range-bound.
In 2028, AIDX is projected to trade between $0.2381 and $0.7205, averaging $0.4017 — a potential decline of -6% from today's $0.4258. That is up +4% on the projected 2027 average. A consolidation phase looks the most probable path here.
20/20 Biolabs, Inc.'s 2029 outlook centres on $0.3584, within a $0.1936 to $0.6859 range. That is -11% versus the projected 2028 average. That marks a -16% change versus current levels. A cyclical pullback looks likely — prices rarely move in a straight line.
By 2030, AIDX could reach as high as $0.6845, with a base case around $0.3393 and support toward $0.168 — roughly -20% from $0.4258. Expect choppier, lower action through this leg of the cycle.
Expect AIDX to range from $0.187 to $0.8673 through 2031. The $0.4112 average target implies a -3% move from current prices. That is up +21% on the projected 2030 average. Price action looks broadly range-bound.
The AIDX price prediction for 2032 points to an average of $0.5255 (low $0.2365, high $1.15) — a potential gain of +23% on today's $0.4258. Buyers look set to stay in control over this stretch.
In 2033, AIDX is projected to trade between $0.2569 and $1.30, averaging $0.5709 — a potential gain of +34% from today's $0.4258. That is up +9% on the projected 2032 average. Momentum favours further upside here.
20/20 Biolabs, Inc.'s 2034 outlook centres on $0.4978, within a $0.224 to $1.15 range. That is -13% versus the projected 2033 average. That marks a +17% change versus current levels. A consolidation phase looks the most probable path here.
By 2035, AIDX could reach as high as $1.10, with a base case around $0.4777 and support toward $0.215 — roughly +12% from $0.4258. Price action looks broadly range-bound.
Expect AIDX to range from $0.3231 to $1.65 through 2040. The $0.7181 average target implies a +69% move from current prices. That is up +50% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The AIDX price prediction for 2050 points to an average of $0.9153 (low $0.4119, high $2.11) — a potential gain of +115% on today's $0.4258. Momentum favours further upside here.
Investing $1,000 in AIDX today (≈ 2,348.520432 AIDX) could be worth
$2,149.61
+$1,149.61 (+115%) by 2050 · US Dollar
Based on the average projected AIDX price of $0.92 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AIDXwould be worth at today's price.
$1,000 invested in AIDX on Feb 19, 2026 (≈ 41.928721 AIDX) would be worth
$17.85
-$982.15 (-98.2%) today · 0.02× · US Dollar
Based on a AIDX entry price of $23.85 vs. today's $0.4258.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.49 | $868.98 | -13.1% |
| 1 month ago | $0.61 | $698.03 | -30.2% |
| 3 months ago | $1.55 | $274.71 | -72.5% |
| All time ago | $23.85 | $17.85 | -98.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AIDX forecast.
Our base-case forecast reaches $0.85 around 2050.
Implied market cap at $0.85: $10.41M
The multi-year forecast lays out a spectrum of outcomes. For 2030, the expected average price is $0.3209, with a min of $0.1587 and a max of $0.6476, and an ROI of -20, with a bearish sentiment. In the next couple of years, 2032 and 2033 show bullish turns, with averages of $0.4945 and $0.5332 and max values up to $1.09 and $1.21, returning ROIs of 23.3 and 32.9 respectively.
By 2040, the forecast envisions a notable step up to an average of $0.6835, a max of $1.57, and an ROI of 70.4, with bullish sentiment. The progression continues to 2050, where the average price is projected at $0.8683, the max at $2.00, and an ROI of 116.5, also bearing a bullish sentiment. These figures illustrate a path from earlier downside risk to substantial long-run upside, acknowledging that these are estimates and not guarantees.
Tap a question to reveal the answer.
2030 min $0.1587, avg $0.3209, max $0.6476, ROI -20, sentiment BEARISH.
Forecasts show a mix of outcomes: neutral in 2026 with average near the current price, bearish in 2030, and bullish in later years such as 2032 (avg $0.4945, ROI 23.3) and 2050 (avg $0.8683, ROI 116.5). These are estimates, not guarantees.
Yes. The year 2033 shows a max of $1.21, 2032 a max of $1.09, and later years reach higher peaks toward $1.57 in 2040 and $2.00 in 2050.
For 2026, min $0.40, avg $0.4011, max $0.5959, ROI 0, sentiment NEUTRAL.
Current price is $0.4011 and market cap is $4.91M, with a market rank of 5006.
20/20 Biolabs, Inc. Community Discussion
0Share your 20/20 Biolabs, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.